John M. Bedtelyon

Array ( [id] => 10844552 [patent_doc_number] => 08871729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Treatment of CNS conditions' [patent_app_type] => utility [patent_app_number] => 12/293230 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12831 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12293230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028921 [patent_doc_number] => 20070270368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATION OF MCL-1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/687535 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22401 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270368.pdf [firstpage_image] =>[orig_patent_app_number] => 11687535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214266 [patent_doc_number] => 08193159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'MCP-1 binding nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/279183 [patent_app_country] => US [patent_app_date] => 2007-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 38882 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193159.pdf [firstpage_image] =>[orig_patent_app_number] => 12279183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185296 [patent_doc_number] => 07645732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Treating hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 11/657856 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3201 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645732.pdf [firstpage_image] =>[orig_patent_app_number] => 11657856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797870 [patent_doc_number] => 20080009456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'ANTISENSE MODULATION OF KINESIN-LIKE 1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/618167 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26756 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009456.pdf [firstpage_image] =>[orig_patent_app_number] => 11618167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446301 [patent_doc_number] => 08288354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Natural antisense and non-coding RNA transcripts as drug targets' [patent_app_type] => utility [patent_app_number] => 12/159607 [patent_app_country] => US [patent_app_date] => 2006-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 40742 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12159607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538180 [patent_doc_number] => 08313901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Methods and compositions related to the modulation of riboswitches' [patent_app_type] => utility [patent_app_number] => 12/158168 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19523 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12158168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404621 [patent_doc_number] => 20090239935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'RNA-HELICASE AS A MARKER FOR RARE TUMORS' [patent_app_type] => utility [patent_app_number] => 12/097662 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9654 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239935.pdf [firstpage_image] =>[orig_patent_app_number] => 12097662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4826840 [patent_doc_number] => 20080125384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'SIMULTANEOUS SILENCING AND RESTORATION OF GENE FUNCTION' [patent_app_type] => utility [patent_app_number] => 11/562281 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4816 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125384.pdf [firstpage_image] =>[orig_patent_app_number] => 11562281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480808 [patent_doc_number] => 20090203765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'MODULATION OF EIF4E-BP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/094598 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203765.pdf [firstpage_image] =>[orig_patent_app_number] => 12094598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239200 [patent_doc_number] => 08603991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Individualized cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/601431 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 17409 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 328 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11601431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056914 [patent_doc_number] => 20070059836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Compositions and methods for regulating genes of interest' [patent_app_type] => utility [patent_app_number] => 11/595104 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6775 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059836.pdf [firstpage_image] =>[orig_patent_app_number] => 11595104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314860 [patent_doc_number] => 07524830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Decoy-containing pharmaceutical compositions and method of using the same' [patent_app_type] => utility [patent_app_number] => 11/580748 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7476 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524830.pdf [firstpage_image] =>[orig_patent_app_number] => 11580748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477390 [patent_doc_number] => 07906490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Circular DNA vectors for synthesis of RNA and DNA' [patent_app_type] => utility [patent_app_number] => 11/523884 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 28647 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906490.pdf [firstpage_image] =>[orig_patent_app_number] => 11523884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983428 [patent_doc_number] => 20070087987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Modulation of glucagon receptor expression' [patent_app_type] => utility [patent_app_number] => 11/524041 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14775 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087987.pdf [firstpage_image] =>[orig_patent_app_number] => 11524041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164506 [patent_doc_number] => 08173612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis' [patent_app_type] => utility [patent_app_number] => 11/521843 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3108 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173612.pdf [firstpage_image] =>[orig_patent_app_number] => 11521843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172387 [patent_doc_number] => 20070072820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512735 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072820.pdf [firstpage_image] =>[orig_patent_app_number] => 11512735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682815 [patent_doc_number] => 20080249041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512725 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10784 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249041.pdf [firstpage_image] =>[orig_patent_app_number] => 11512725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172386 [patent_doc_number] => 20070072819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512730 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10774 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072819.pdf [firstpage_image] =>[orig_patent_app_number] => 11512730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107677 [patent_doc_number] => 20070066555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/512728 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10590 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066555.pdf [firstpage_image] =>[orig_patent_app_number] => 11512728 [rel_patent_id] =>[rel_patent_doc_number] =>)